Results

Total Results: 9,462 records

Showing results for "cancer".
Users also searched for: colon cancer screening

221. Errors in cancer diagnosis: current understanding and future directions. | PSNet
     psnet.ahrq.gov/issue/errors-cancer-diagnosis-current-understanding-and-future-directions
     November 18, 2009 - Errors in cancer diagnosis: current understanding and future directions. … Errors in cancer diagnosis: current understanding and future directions. … October 9, 2017 Safety and diagnostic accuracy of tumor biopsies in children with cancer … October 10, 2012 Rates of new or missed colorectal cancers after colonoscopy and their … August 10, 2011 Missed breast cancers at US-guided core needle biopsy: how to reduce

222. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/pth_4-Mnau_pZubaefDvUk
     January 01, 2020 - Most of the additional cancer detected by these methods are inva- sive tumors rather than ductal carcinoma … Although adjunctive screening may de- tect more breast cancer, these cancers may fall into 1 of 3 categories … (that is, cancer with adverse histologic features, such as poorly differentiated tumors and triple-negative … , but the tumor does not go on to behave as expected based on its appearance. … the tumor stops progressing at an early invasive stage.

223. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. | PSNet
     psnet.ahrq.gov/issue/effect-delays-2-week-wait-cancer-referral-pathway-during-covid-19-pandemic-cancer-survival-uk
     October 21, 2020 - Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival … referrals on cancer survival. … proportion of patients with early-stage tumors progressing from having curable to incurable disease. … Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival … cancer during the COVID-19 pandemic.

224. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/8dzfZ_s3tZueoEh5Xzh-3A
     July 26, 2016 - S kin cancer is among the most common cancers in men and women in the United States,1 and classified … as either non- melanoma skin cancer (NMSC) (ie, basal cell and squamous cell cancers) or melanoma skin … Although NMSC represents more than 97% of skin cancers,1 melanoma skin cancer is the pri- mary public … 1.01 to 2.00 mm, 4.69 (95% CI, 4.24-5.02) for tumors 2.01 to 4.00 mm, and 5.71 (95% CI, 5.10-6.39) for … tumors larger than 4.00 mm.

225. Colorectal Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/colorectal-cancer

226. Archived: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening-2012
     May 15, 2012 - by PSA screening have a tumor that either will not progress or will progress so slowly that it would … On the basis of PSA level, Gleason score, and tumor stage, approximately 43% had low-risk tumors, 36% … had intermediate-risk tumors, and 21% had high-risk tumors. … The 10-year prostate cancer mortality rate for well- or moderately-differentiated tumors among men aged … The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients.

227. Breast cancer screening and overdiagnosis. | PSNet
     psnet.ahrq.gov/issue/breast-cancer-screening-and-overdiagnosis
     March 16, 2022 - Breast cancer screening and overdiagnosis. … Int J Cancer. 2021;149(4):846-853. doi:10.1002/ijc.33602. … Breast cancer screening and overdiagnosis. … Int J Cancer. 2021;149(4):846-853. doi:10.1002/ijc.33602. … March 8, 2023 Breast cancer screening in Denmark: a cohort study of tumor size and overdiagnosis

228. Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/cHbBWNok76hRWKDXXm3R2_
     February 13, 2018 - volume >10 cm3; any solid area or papillary projection extending into the cavity of a cystic ovarian tumor … of any size; or any mixed (solid and cystic) component within a cystic ovarian tumor Notification of … Tumors of the peritoneum: epithelial tumors of Müllerian type. … WHO Classification of Tumors of Female Reproductive Organs. 4th ed. … of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer

229. Pancreatic Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/pancreatic-cancer

230. Screening for Bladder Cancer: Clinical Summary of U.S. Preventive Services Task Force Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/p8huvc8UM4WfAnrNAzYnXS
     Screening for Bladder Cancer: Clinical Summary of U.S. … is transurethral resection of the bladder tumor, which may be combined with adjuvant radiation therapy … There is inadequate evidence on harms of screening for bladder cancer. … the following: Potential preventable burden: early detection of tumors with malignant potential could … have an important impact on the mortality rate of bladder cancer.

231. Archived: Breast Cancer: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening-1996
     January 01, 1996 - in women are cancers of the breast, the most common cancer diagnosed in women. 1 The annual incidence … compared to the total of screen-detected cancers plus interval cancers, but one may use a fixed interval … A recent analysis of data by tumor size, nodal status, and stage from the BCDDP, a U.S. screening project … patients in the two groups did not differ in number, size, or nodal status of their tumors. … , and varying biologic characteristics of breast tumors. 52 , 72 The Swedish overview, 40 HIP, 37

232. Final Research Plan: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breast-cancer-screening
     May 06, 2021 - and across followup, including interval cancers Cancer subtypes will be defined by receptor status … different stage and tumor size cutpoints) * KQ 3: False-positive and false-negative findings at … abstracts of non–English-language papers)   * Where possible we will report outcomes for cancers … include certain types of nonrandomized studies for the assessment of effectiveness, and include interval cancers … The USPSTF also clarified the proposed approach for including interval cancers and for defining advanced

233. Archived: Evidence Summary: Collaborative Modeling of U.S. Breast Cancer Screening Strategies: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-collaborative-modeling-of-us-breast-cancer-/breast-cancer-screening-january-2016
     January 11, 2016 - Models M and W also assumed some small nonprogressive invasive cancers. … for invasive cancers only). … Those with HER2-positive tumors also received trastuzumab. … The MISCAN-Fadia continuous tumor growth model for breast cancer. … Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection

234. Imaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/liver-cancer/research

235. Prostate-Cancer-Risk-Assessment-Genes Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_executive.pdf
     July 01, 2012 - Background Prostate cancer is the fifth most common malignancy in the world,1 with a large variation … is indolent, and it is difficult to predict which tumors will be aggressive. … and no increase in the AUC of a model based on age, PSA, Gleason score, and tumor stage when SNPs … American Cancer Society. Cancer Facts & Figures 2010. … Two genome- wide association studies of aggressive prostate cancer implicate putative prostate tumor

236. Screening for Prostate Cancer: Clinical Summary of USPSTF Recommendation (2012) (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/JosR5xCYBoK6K9BTbsaQD3
     Screening for Prostate Cancer: Clinical Summary of USPSTF Recommendation (2012) SCREENING FOR PROSTATE … CANCER CLINICAL SUMMARY OF U.S. … a tumor that either will not progress or will progress so slowly that it would have remained asymptomatic … Because of the current inability to reliably distinguish tumors that will remain indolent from those … The benefits of PSA-based screening for prostate cancer do not outweigh the harms.

237. Screening for Skin Cancer: Recommendations and Rationale (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/j-FyHoTDHNJu_qmotFzJq3
     February 15, 2001 - , or squamous cell skin cancer. … (“A,” “B,” “C,” “D”), or rapidly changing lesions are features associated with an increased risk of malignancy … from melanoma, but early de- tection and treatment may reduce morbidity and dis- figurement from these cancers … No studies were found that evaluated whether screening improves the out- comes of these cancers. … American Cancer Society. Melanoma: detection and symptoms.

238. Archived: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
     March 15, 2007 - More than 80% of colorectal cancers arise from adenomatous polyps. … represents the third most common cause of cancer and has the second highest mortality rate among cancers … of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia … Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent … Low-dose aspirin and incidence of colorectal tumors in a randomized trial.

239. Screening for Skin Cancer: An Update of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/LgBN7_z7hqynt6BRzUUYA-
     February 01, 2009 - The majority of skin cancer is nonmelanoma cancer, either basal cell cancer or squamous cell cancer. … The majority of skin cancer is nonmelanoma cancer, either basal cell cancer or squamous cell cancer … cell cancer (5). … We used the terms skin neoplasms, squamous cell neo­ plasms, basal cell neoplasms, melanoma, and mass … whole-body examination by primary care clinicians or by self-examination accurately detect skin cancers

240. Protocol: Imaging for Pretreatment Staging of Small Cell Lung Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
     December 08, 2014 - cell lung cancer (SCLC) comprises approximately 15% of all lung cancers.2 The five-year survival rate … Lung cancers are classified based on the size of the main tumor, whether it has locally invaded other … '/de OR cancer OR tumor* OR tumour* OR mass* OR neoplasm* AND (stage OR 'staging'/de OR staging OR class … OR tumor* OR tumour* OR mass* OR neoplasm*) AND (stage OR staging OR class*) Source: www.effectivehealthcare.ahrq.gov … [tiab] OR neoplasm[tiab] OR tumor*[tiab] OR tumour*[tiab]) AND (care[tiab] OR treatment[tiab] OR therapy